Fig. 5From: Construction and validation of a two-gene signature based on SUMOylation regulatory genes in non-small cell lung cancer patientsThe association between high-risk group patients and cancer-related pathway. A-C the top enriched biological processes, cellular components, and molecular functions analysis of high- versus low-risk groups. D-I The cancer-related pathways enriched in high-risk group patientsBack to article page